Chronic Complications of Diabetes

Slide 1 · Chronic complications of diabetes

Persistent hyperglycemia drives cumulative tissue injury in both type 1 and type 2 diabetes.

Large and medium arteries develop accelerated atherosclerosis.

Small-vessel injury is prominent in the retina, kidneys and nerves.

Metabolic pathways link glucose excess to inflammation, matrix accumulation and oxidative stress.

Chronic diabetes

Macrovascular disease

Microangiopathy

End-organ dysfunction

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Explain chronic diabetic injury from metabolic pathways to organ damage.

Distinguish macrovascular from microvascular complications.

Trace AGE–RAGE, DAG–PKC, polyol and hexosamine pathways.

Link vascular and cellular injury to renal, retinal and neural lesions.

Interpret common clinicopathologic patterns and mechanisms.

Slide 3 · Anatomical scale determines the dominant injury

Diabetic vascular injury affects several vessel sizes, with different consequences.

Arteries: Accelerated atherosclerotic plaque burden.

Arterioles and capillaries: Basement membrane and hyaline change.

Microvascular lesions disrupt tissue exchange despite thickened basement membranes.

Large and medium arteries

Atherosclerosis

Myocardial infarction

Stroke / limb ischemia

Microvasculature

Basement membrane thickening

Renal / retinal injury

Some neuropathy

Slide 4 · A multisystem disease

Organ manifestations differ, but share chronic exposure to metabolic and vascular stress.

Heart and brain: Ischemic events due to macrovascular disease.

Kidney: Glomerular and microvascular structural damage.

Eye: Retinal microangiopathy and lens abnormalities.

Nerves and foot: Sensory loss compounded by ischemia and infection.

Chronic glucose excess

Heart / brain

Kidney

Retina / lens

Peripheral nerves

Slide 5 · Exposure precedes overt organ dysfunction

Complications reflect cumulative disease burden, not a single glucose measurement.

Degree and duration of hyperglycemia both matter.

Structural changes may precede clinical symptoms.

Intervening on glycemia attenuates end-organ damage; Risk does not disappear completely.

Persistent exposure

Molecular injury

Tissue remodeling

Clinical disease

Slide 6 · The same core pathways operate in both types

Type 1 and type 2 diabetes converge on sustained hyperglycemia.

Type 1 diabetes: Absolute insulin deficiency is the central disturbance.

Type 2 diabetes: Insulin resistance and β-cell dysfunction coexist.

Once persistent hyperglycemia occurs, overlapping mechanisms injure vessels and organs.

Type 1 diabetes

Absolute insulin deficiency

Chronic hyperglycemia

Type 2 diabetes

Insulin resistance + β-cell dysfunction

Chronic hyperglycemia

Slide 7 · Glucotoxicity is not simply osmotic stress

Excess intracellular glucose alters signaling and generates injurious intermediates.

Glycation creates reactive AGE-related products.

Glycolytic intermediates feed DAG–PKC and hexosamine pathways.

Polyol metabolism competes for NADPH needed by antioxidant defenses.

Excess intracellular glucose

AGE formation

DAG → PKC

Sorbitol / NADPH

Hexosamine flux

Slide 8 · Four pathways organize chronic glucotoxicity

The pathways overlap but each illustrates a distinct biochemical route.

AGE–RAGE: Extracellular/intracellular protein modification and receptor signaling.

DAG–PKC: Altered endothelial signaling and gene expression.

Polyol pathway: NADPH consumption, oxidative stress and sorbitol.

Hexosamine pathway: Proposed damage from diverted glycolytic intermediates.

Pathway

Primary distinctive feature

AGE–RAGE

Protein glycation + receptor activation

PKC

DAG-mediated kinase activation

Polyol

Aldose reductase uses NADPH

Hexosamine

Increased intermediary flux

Slide 9 · Glycemic-control evidence supports causality

Prospective randomized studies link improved control with less long-term damage.

HbA1c was used to assess mean glycemic exposure in major trials.

Better glycemic control attenuates complication development.

The association supports a major causal role for sustained hyperglycemia, not exclusive causation.

Glycemic intervention

Reduced mean glucose exposure

Less cumulative injury

Slide 10 · Why HbA1c reflects sustained glycemia

Hemoglobin undergoes nonenzymatic glycation inside circulating red cells.

Glucose reacts covalently with hemoglobin over red-cell survival.

Measured HbA1c reflects integrated exposure over approximately 120-day red-cell lifespan.

A single blood glucose value captures a much shorter interval.

Circulating glucose

Hemoglobin glycation

Accumulated HbA1c

Slide 11 · Spot glucose and HbA1c answer different questions

Both measurements are relevant, but describe different aspects of glycemia.

Spot glucose: Concentration at the sampling time.

HbA1c: Index of longer-term glycemic exposure.

Day-to-day glucose fluctuations affect spot measurements much more strongly.

Blood glucose

Snapshot in time

Sensitive to short-term variation

HbA1c

Cumulative red-cell exposure

Less sensitive to day-to-day variation

Slide 12 · Interpreting the textbook HbA1c target

The primary source recommends an HbA1c below 7% for most people with diabetes.

This is a general textbook treatment goal, not a diagnostic threshold.

Complication risk relates to exposure across time.

Individualized targets and contemporary clinical recommendations are outside this source-bound lecture.

Glucose exposure

HbA1c assessment

Risk-reduction efforts

Slide 13 · Continuous monitoring adds a second exposure metric

Time-in-range describes the portion of monitored time glucose stays within a chosen target band.

Continuous glucose monitoring measures changing glycemia.

Increasing time-in-range as an emerging goal.

It may predict complication risk better than HbA1c in some settings; The source does not establish equivalence.

HbA1c

Long-term glycemic summary

Averages fluctuations

Time-in-range

Captures duration in target band

Reflects temporal glucose patterns

Slide 14 · Glycemic control does not explain all risk

Diabetes-associated comorbidities and metabolic disturbances modify tissue injury.

Insulin resistance contributes independently to metabolic dysfunction.

Obesity is a relevant comorbidity.

Hypertension and dyslipidemia amplify vascular events in diabetes.

A comprehensive risk model is broader than average glucose alone.

End-organ damage

Persistent hyperglycemia

Insulin resistance

Obesity

Hypertension / dyslipidemia

Slide 15 · AGE formation begins with nonenzymatic chemistry

Glucose-derived dicarbonyl intermediates react with protein amino groups.

The source names glyoxal, methylglyoxal and 3-deoxyglucosone.

These intermediates modify intracellular and extracellular proteins.

Persistent hyperglycemia accelerates the formation rate.

Glucose-derived metabolites

Reaction with protein amino groups

Advanced glycation end products

Slide 16 · Reactive AGE precursors are chemically distinct

Different glucose-derived metabolites feed a shared class of protein modifications.

Glyoxal is a reactive glucose-derived carbonyl compound.

Methylglyoxal is another named precursor of AGE chemistry.

3-Deoxyglucosone also participates in nonenzymatic glycation.

The lecture does not imply that all AGEs share one structure.

Protein amino groups

Glyoxal

Methylglyoxal

3-Deoxyglucosone

Slide 17 · AGE formation has two routes to injury

Protein modification and AGE receptor signaling are conceptually separable.

Modification changes the biochemical environment of tissue proteins.

AGEs also act through the cell-surface receptor RAGE.

RAGE-dependent responses especially affect the vascular and inflammatory compartments.

Protein modification

Covalent glycation

Intracellular / extracellular proteins

Receptor route

AGE ligands engage RAGE

Activation of injury signaling

Slide 18 · RAGE is expressed in multiple injury-relevant cells

The source identifies receptors in vascular and inflammatory populations.

Endothelial cells: A direct vascular signaling target.

Vascular smooth muscle: Remodeling and proliferation.

Macrophages and T lymphocytes: Inflammatory signaling.

AGE → RAGE

Endothelium

Vascular smooth muscle

Macrophages

T cells

Slide 19 · AGE–RAGE initiates a vascular injury network

One receptor system can produce several mutually reinforcing consequences.

Cytokine and growth-factor release alters vessel-wall structure.

Endothelial reactive oxygen species intensify cell injury.

Procoagulant activity alters the vascular interface.

Smooth muscle proliferation and matrix synthesis promote remodeling.

AGE–RAGE activation

TGF-β / VEGF

Endothelial ROS

Procoagulant activity

Smooth muscle / matrix

Slide 20 · TGF-β connects inflammation to basement membrane expansion

RAGE-related cytokine/growth-factor release includes transforming growth factor β.

TGF-β favors deposition of excess basement membrane material.

Chronic matrix deposition alters microvascular architecture.

Basement membrane thickening is a morphologic signature of diabetic microangiopathy.

AGE–RAGE signaling

TGF-β release

Excess matrix / basement membrane deposition

Slide 21 · VEGF connects vascular stress to retinal disease

Vascular endothelial growth factor has particular relevance to the diabetic retina.

AGE–RAGE signaling can enhance VEGF-related responses.

Retinal hypoxia further induces VEGF expression.

Pathologic neovascularization characterizes proliferative retinal disease.

Microvascular injury

Retinal hypoxia / VEGF

Neovascularization

Slide 22 · AGE–RAGE produces endothelial oxidant stress

Reactive oxygen species are among the identified downstream effects.

Endothelial cells generate ROS after AGE–RAGE activation.

Oxidants intensify dysfunction of the vascular lining.

Other pathways also increase oxidative susceptibility, so ROS is a point of convergence.

Endothelial oxidative injury

AGE–RAGE → ROS

Polyol → weaker GSH defense

Hexosamine: Proposed oxidative stress

Slide 23 · Procoagulant effects are part of endothelial dysfunction

AGE–RAGE signaling enhances thrombogenic activity in vascular cells.

The source identifies endothelial cells and macrophages as sites of procoagulant activation.

A procoagulant vessel wall favors atherothrombotic complications.

This is one component of diabetic vascular injury, not the sole cause of thrombosis.

AGE–RAGE

Endothelial / macrophage activation

Procoagulant surface

Slide 24 · Smooth muscle responses promote vessel-wall remodeling

AGE–RAGE influences cells beyond the endothelium.

Vascular smooth muscle proliferation increases.

Extracellular matrix synthesis also increases.

Together with endothelial dysfunction, these changes contribute to vascular disease.

AGE–RAGE

Smooth muscle cell activation

Proliferation + matrix synthesis

Slide 25 · Experimental RAGE manipulations support mechanism

Animal studies implicate RAGE, but are not direct proof of clinical treatment benefit.

Endothelial RAGE overexpression accelerated vessel injury in diabetic mice.

RAGE-null mice showed attenuation of vascular damage.

Potential RAGE antagonism is presented by the textbook as an investigational approach.

More RAGE signaling

Greater vascular injury

Experimental diabetic mice

Absent RAGE

Attenuated injury

Experimental RAGE-null mice

Slide 26 · DAG–PKC represents a signaling pathway

Hyperglycemia can induce kinase signaling without AGE receptor ligation.

Glycolytic intermediates feed de novo synthesis of diacylglycerol (DAG).

DAG promotes protein kinase C (PKC) activation.

PKC changes endothelial expression of growth and procoagulant mediators.

Intracellular hyperglycemia

DAG synthesis

PKC activation

Downstream mediators

Slide 27 · DAG links glucose metabolism to kinase activation

A metabolite ordinarily used in signaling becomes excessive with intracellular glucose abundance.

Excess glycolytic intermediates increase DAG formation.

DAG is an important second messenger in PKC-related signaling.

The source describes excessive rather than physiologic activation.

Glucose-derived intermediates

Increased DAG

Excess PKC signaling

Slide 28 · PKC activation enhances endothelial VEGF

The molecular pathway converges on the retina-relevant growth factor.

Activated PKC promotes vascular endothelial VEGF production.

VEGF contributes to retinal neovascular responses.

AGE–RAGE and PKC therefore reinforce related outputs.

DAG → PKC

VEGF production

Retinal vascular response

Slide 29 · PKC activation also promotes TGF-β

This connects kinase dysregulation to matrix deposition.

Endothelial PKC activation increases TGF-β-related signaling.

TGF-β supports deposition of extracellular and basement membrane material.

Progressive matrix expansion underlies characteristic microvascular changes.

DAG → PKC

TGF-β

Basement membrane accumulation

Slide 30 · PAI-1 is a procoagulant pathway output

The source identifies plasminogen activator inhibitor-1 among PKC-induced proteins.

Endothelial PKC signaling increases PAI-1.

PAI-1 inhibits plasminogen activation and hence opposes fibrinolysis.

This mechanistic interpretation helps explain a more prothrombotic vascular milieu.

Hyperglycemia

PKC activation

PAI-1 production

Reduced fibrinolytic tendency

Slide 31 · AGE–RAGE and PKC share downstream effectors

Pathways should not be taught as independent silos.

Both can increase TGF-β-associated matrix deposition.

Both can promote VEGF-related endothelial responses.

Oxidant and procoagulant effects add to vessel-wall dysfunction.

Pathway

TGF-β

VEGF

Additional effects

AGE–RAGE

Yes

Yes

ROS; Procoagulant activity

PKC

Yes

Yes

PAI-1 expression

Slide 32 · Microangiopathy reflects pathway convergence

Multiple inputs lead to a common structural phenotype.

Growth-factor signaling increases basement membrane matrix.

Endothelial oxidant and procoagulant responses impair function.

Persistent microvascular remodeling contributes to retina, glomerular and nerve injury.

Small-vessel injury

TGF-β → matrix

ROS → endothelial dysfunction

VEGF → retinal responses

Coagulant changes

Slide 33 · Polyol metabolism uses an antioxidant cofactor

Some tissues take up glucose without requiring insulin to transport it.

Excess intracellular glucose becomes substrate for aldose reductase.

Aldose reductase converts glucose into sorbitol.

The reaction requires NADPH, which is also needed for antioxidant maintenance.

Excess intracellular glucose

Aldose reductase + NADPH

Sorbitol

Slide 34 · Polyol-sensitive tissues include several organs

Persistent hyperglycemia can increase intracellular glucose in insulin-independent tissues.

Peripheral nerves and lenses are highlighted by the textbook.

Kidneys and vascular tissues are additional examples.

These compartments are susceptible to metabolic injury despite not depending on insulin for glucose entry.

Insulin-independent uptake

Peripheral nerves

Lens

Kidney

Blood vessels

Slide 35 · Aldose reductase diverts glucose to sorbitol

The first step creates both a polyol and competition for NADPH.

Aldose reductase catalyzes glucose → sorbitol.

Sorbitol can be converted further to fructose.

The first reaction consumes reducing capacity supplied by NADPH.

Glucose

Aldose reductase

Sorbitol

Fructose

Slide 36 · NADPH availability is a metabolic bottleneck

Polyol flux and antioxidant regeneration rely on the same reduced cofactor.

Increased aldose reductase activity draws on NADPH.

Glutathione reductase also uses NADPH.

Intense polyol flux therefore compromises the regeneration of reduced glutathione.

NADPH demand

Aldose reductase → sorbitol

Glutathione reductase → GSH regeneration

Slide 37 · Reduced glutathione protects against oxidants

The polyol pathway creates injury partly by reducing antioxidant capacity.

Glutathione reductase regenerates reduced glutathione (GSH).

GSH is an important intracellular antioxidant defense.

Reduced NADPH availability can limit GSH regeneration.

NADPH availability

Glutathione reductase

Reduced GSH

ROS protection

Slide 38 · Polyol flux can amplify oxidative stress

The critical injury is not simply the presence of sorbitol.

Excess glucose increases NADPH utilization by aldose reductase.

Lower NADPH availability compromises GSH regeneration.

Weakened antioxidant buffering increases susceptibility to ROS damage.

Excess polyol flux

NADPH depletion

Lower GSH regeneration

Oxidative stress

Slide 39 · Sorbitol accumulation contributes to cataracts

The lens is an important nonvascular target of glucose excess.

Sorbitol may accumulate during sustained polyol metabolism.

The textbook links lens sorbitol accumulation with cataract formation.

Lens injury is distinct from microangiopathy of retinal vessels.

Lens

Sorbitol accumulation

Cataract formation

Retina

Microvascular injury

VEGF-associated neovascularization

Slide 40 · Polyol and AGE injury converge on oxidants

Oxidative stress can be increased by more than one route.

AGE–RAGE signaling stimulates endothelial ROS production.

Polyol flux reduces cellular antioxidant regeneration.

Thus oxidant production and impaired clearance may coexist.

Increased ROS generation

AGE–RAGE effects

Endothelial production

Reduced defense

NADPH diverted

GSH regeneration impaired

Slide 41 · Hexosamine metabolism is a fourth proposed route

Diversion of intermediates toward hexosamine metabolism is implicated in injury.

Hyperglycemia increases flux of glycolytic intermediates through this route.

The source links this pathway to cell damage and oxidative stress.

Consequences including insulin resistance and vascular complications remain mechanistic proposals.

Glycolytic intermediate flux

Hexosamine pathway

Cell stress / vascular injury

Slide 42 · The hexosamine mechanism has different certainty

The source explicitly frames the proposed chain as a postulate.

Increased metabolic flux is the initiating concept.

Oxidative injury and insulin resistance are proposed downstream effects.

Avoid presenting a specific intermediary or quantitative impact that is not documented in this source.

Established in excerpt

Hyperglycemia increases pathway flux

Proposed consequences

Oxidative cellular injury

Insulin resistance / vascular complications

Slide 43 · Metabolic routes summarized by their key intermediates

Each pathway begins with increased glucose or glycolytic flux.

AGE chemistry involves reactive glucose-derived metabolites.

PKC activation follows increased DAG synthesis.

Polyol injury features NADPH consumption and sorbitol.

Hexosamine injury is attributed to increased pathway flux.

Pathway

Intermediate / signal

Principal injury link

AGE–RAGE

Glyoxal / methylglyoxal / AGE

Inflammation; Matrix; Oxidants

DAG–PKC

Diacylglycerol

VEGF; TGF-β; PAI-1

Polyol

Sorbitol + NADPH use

Less GSH; Lens injury

Hexosamine

Increased pathway flux

Proposed oxidative/cellular stress

Slide 44 · Cells translating metabolism into vascular pathology

The principal participating cells are different from those forming the final scar.

Endothelium: Oxidative, growth-factor and procoagulant signaling.

Smooth muscle: Increased proliferation and matrix synthesis.

Macrophages and T cells: Inflammatory receptor responses.

Organ parenchyma also becomes injured downstream of microvascular disturbance.

Cellular response

Endothelium

Smooth muscle

Macrophage / T cell

Organ parenchyma

Slide 45 · Basement membrane thickening is not protective

The diabetic capillary wall may become thicker but more permeable.

Diffuse basement membrane thickening is an established morphologic feature.

Capillaries paradoxically become leakier to plasma proteins.

Structural accumulation does not imply normal microvascular barrier function.

Morphologic change

Basement membrane thickens

Excess matrix

Functional change

Permeability increases

Plasma proteins leak

Slide 46 · Diabetic microangiopathy spans several tissues

Basement membrane remodeling occurs in multiple vascular and nonvascular sites.

Capillaries in skin, muscle, retina and kidney are affected.

Nonvascular basement membranes of renal tubules and peripheral nerves may thicken.

This distribution helps explain multisystem clinical manifestations.

Microangiopathy

Retinal capillaries

Glomeruli / renal medulla

Skin / skeletal muscle

Peripheral nerves

Slide 47 · How microvascular morphology follows biochemistry

Matrix growth and vascular dysfunction explain the core microscopic pattern.

TGF-β-related signaling promotes excess matrix production.

Endothelial dysfunction accompanies thickened basement membranes.

Leakiness and tissue ischemia help translate structural change into functional loss.

Biochemical stress

Matrix + endothelial changes

Microangiopathy

Organ injury

Slide 48 · Macrovascular disease is accelerated atherosclerosis

Large-vessel lesions resemble conventional atherosclerotic plaques morphologically.

Diabetes accelerates disease in aorta and muscular arteries.

Persistent hyperglycemia and insulin resistance contribute to endothelial dysfunction.

Clinical outcomes depend on the affected vascular territory.

Endothelial dysfunction

Accelerated atherosclerosis

Ischemic events

Slide 49 · Coronary disease is a major lethal complication

The coronary arterial bed is a critical macrovascular target.

Accelerated coronary atherosclerosis predisposes to myocardial infarction.

Myocardial infarction as the most common cause of death in diabetes.

Associated hypertension and dyslipidemia increase cardiovascular burden.

Coronary plaque

Coronary flow limitation / occlusion

Myocardial infarction

Slide 50 · Cerebrovascular complications share arterial mechanisms

Macrovascular disease increases risk of ischemic brain injury.

Cerebral artery atherosclerosis contributes to ischemic stroke.

Diabetes can coexist with hypertension, adding vascular risk.

The mechanism is primarily large-artery disease, not identical to retinal microangiopathy.

Brain

Cerebrovascular atherosclerosis

Ischemic stroke risk

Retina

Capillary/microvascular injury

VEGF-related changes

Slide 51 · Peripheral arterial disease threatens limb viability

Lower-extremity ischemia reflects the arterial component of diabetic foot pathology.

Accelerated peripheral atherosclerosis limits perfusion.

Tissue ischemia impairs resistance to local injury.

When neuropathy and infection coexist, gangrene risk rises markedly.

Peripheral artery disease

Limb ischemia

Poor healing

Gangrene risk

Slide 52 · Diabetic nephropathy includes three lesion groups

Kidney injury is more complex than glomerulosclerosis alone.

Glomerular lesions: Basement membrane and mesangial change.

Renal vessel lesions: Especially arteriolosclerosis.

Infection-related injury: Pyelonephritis, sometimes papillary necrosis.

Diabetic renal injury

Glomerulopathy

Arteriolosclerosis

Pyelonephritis / papillitis

Slide 53 · Glomerular basement membrane thickening

Glomerular capillary walls develop increased basement membrane material.

The source describes this in virtually all cases of diabetic nephropathy.

Electron microscopy demonstrates the structural thickening.

Mesangial expansion and tubular basement membrane changes frequently coexist.

Microvascular matrix response

Thicker glomerular basement membrane

Renal filtration injury

Slide 54 · Diffuse mesangial sclerosis

Increased mesangial matrix is a central renal lesion.

Mesangial expansion is diffuse rather than restricted to one nodule.

Deposited matrix is periodic acid–Schiff (PAS) positive.

Progressive expansion correlates with worsening renal function and proteinuria.

Excess mesangial matrix

Diffuse glomerular expansion

Increased proteinuria

Slide 55 · Nodular glomerulosclerosis

The Kimmelstiel–Wilson pattern consists of peripheral mesangial matrix nodules.

Nodules are ovoid or spherical and PAS positive.

Patent or dilated capillary loops may surround nodules.

Diffuse mesangial sclerosis also occurs in uninvolved glomerular areas.

Diffuse lesion

Generalized mesangial matrix

PAS-positive expansion

Nodular lesion

Discrete peripheral mesangial nodules

Kimmelstiel–Wilson pattern

Slide 56 · Renal arteriolar hyalinosis has a distinctive pattern

Diabetes affects glomerular inflow and outflow arterioles.

Afferent and efferent arterioles may both show hyaline thickening.

Efferent arteriolar hyalinosis is unusual without diabetes.

Ischemic injury contributes to tubular atrophy and interstitial fibrosis.

Arteriolar hyalinosis

Renal ischemia

Tubular atrophy + fibrosis

Slide 57 · Retinal disease links hypoxia to VEGF

Microvascular injury drives a hypoxic proliferative response.

Diabetic retinopathy ranges from background to proliferative patterns.

Hypoxia induces retinal VEGF expression.

Pathologic new vessel formation underlies the proliferative complication.

Retinal vascular injury

Local hypoxia

VEGF induction

Neovascularization

Slide 58 · Lens and retinal disease have different substrates

Not all diabetic eye disease is microangiopathy.

Lens cataract: Opacification associated with glucose-related lens injury.

Retinal disease: Microvascular dysfunction and VEGF-related vessel formation.

Glaucoma may also coexist, but should not be equated with the polyol mechanism.

Site

Prominent process

Consequence

Lens

Polyol / sorbitol-related injury

Cataract

Retina

Microangiopathy; VEGF response

Retinopathy

Optic nerve

Glaucoma-associated damage

Visual dysfunction

Slide 59 · Peripheral neuropathy is often length dependent

Neural injury has a characteristic sensorimotor distribution.

Distal symmetric polyneuropathy often begins in the lower limbs.

Later extension to hands produces a glove-and-stocking pattern.

Microvascular compromise and intracellular glucotoxicity provide mechanistic context.

Long-standing diabetes

Distal neural dysfunction

Glove-and-stocking pattern

Slide 60 · Autonomic and focal neuropathies differ

Diabetic neural complications are not limited to distal sensory loss.

Autonomic injury may disturb bowel and bladder function.

Erectile dysfunction is another autonomic manifestation.

Mononeuropathies may cause focal limb weakness or cranial nerve palsies.

Autonomic neuropathy

Bowel / bladder disturbance

Erectile dysfunction

Mononeuropathy

Footdrop or wristdrop

Cranial nerve palsy

Slide 61 · The diabetic foot is a convergent clinical problem

Neuropathy, ischemia and infection together worsen tissue injury.

Sensory impairment can allow a minor toe injury to go unnoticed.

Poor perfusion limits tissue recovery and immune-cell delivery.

Altered immune responses increase susceptibility to infection.

Progression may include gangrene and systemic infection.

Foot-tissue risk

Loss of protective sensation

Peripheral ischemia

Impaired immune defense

Slide 62 · The host response to infection is impaired

Diabetes can alter leukocyte function as well as vessel perfusion.

Neutrophil chemotaxis, adherence, phagocytosis and killing may be reduced.

Macrophage cytokine responses can be impaired.

Vascular compromise obstructs delivery of host-defense components.

Immune dysfunction + poor perfusion

Infection susceptibility

Local injury progression

Slide 63 · Clinical risk is multifactorial

Glycemic exposure acts alongside comorbidity and organ-specific vulnerability.

Duration and degree of glucose elevation predict cumulative microvascular stress.

Hypertension, dyslipidemia and insulin resistance add cardiovascular risk.

Different tissues express different final injury patterns despite shared upstream stress.

Complication risk

Hyperglycemia

Duration

Vascular comorbidities

Tissue susceptibility

Slide 64 · Case: New albuminuria after years of diabetes

A patient develops persistent urinary albumin and rising blood pressure.

Relevant structural lesion: Diabetic glomerular and mesangial injury.

Potential vascular co-lesion: Arteriolar hyalinosis.

Reasoning task: Connect basement membrane/matrix injury to protein leakage and renal decline.

Chronic microvascular stress

Glomerular remodeling

Albuminuria

Slide 65 · Case: Progressive retinal vascular changes

A long-standing diabetic patient develops retinal new-vessel formation.

Identify the vascular category: Microvascular disease.

Infer hypoxia-associated VEGF upregulation as a principal mechanism.

Explain why this differs from sorbitol-associated lens opacification.

Retinal injury

Hypoxic VEGF signaling

New vessel formation

Slide 66 · Case: An infected toe with reduced sensation

A small unnoticed toe lesion progresses despite initial limited symptoms.

Distal neuropathy reduces protective sensory warning.

Atherosclerotic ischemia reduces local perfusion.

Impaired immune function and microbial invasion can compound damage.

Progressive foot injury

Neuropathy

Ischemia

Susceptibility to infection

Slide 67 · Mechanism-to-organ mapping

The location of injury determines the clinically visible phenotype.

Retina: Microangiopathy and VEGF-related neovascularization.

Kidney: Basement membrane change, mesangial sclerosis and albuminuria.

Nerves: Metabolic and microvascular stress with peripheral/autonomic deficits.

Large arteries: Atherosclerotic ischemic events.

Tissue

Dominant mechanism/lesion

Clinical correlate

Retina

Microvascular injury / VEGF

Retinopathy

Kidney

Matrix expansion; Arterioles

Nephropathy

Nerves

Metabolic + vascular injury

Neuropathy

Large arteries

Accelerated atherosclerosis

MI / stroke / limb ischemia

Slide 68 · Mechanistic checkpoint

Choose the intermediate or mediator that best distinguishes each route.

Reactive carbonyls and RAGE → advanced glycation pathway.

DAG and PKC → kinase signaling pathway.

Sorbitol with NADPH use → polyol pathway.

Diversion of glycolytic intermediates → hexosamine pathway.

Clue

Mechanistic answer

Methylglyoxal / RAGE

AGE pathway

DAG / VEGF / PAI-1

PKC pathway

Sorbitol / NADPH / GSH

Polyol / oxidative stress

Intermediate pathway flux

Hexosamine pathway

Slide 69 · Integrated causal chain

The most useful explanation links glucose excess to altered tissue structure and function.

Chronic glucose exposure increases injurious metabolic flux.

Receptor, kinase and redox changes disrupt endothelial homeostasis.

Matrix expansion, leakiness and ischemic injury follow.

Organ-specific structural and clinical complications emerge over time.

Glucose excess

Biochemical responses

Vascular/tissue injury

Organ complications

Slide 70 · Six take-home principles

Chronic diabetic pathology is a set of converging, cumulative injury mechanisms.

Macrovascular = accelerated atherosclerosis; Microvascular = small-vessel injury.

AGE–RAGE and DAG–PKC share VEGF and TGF-β outputs.

Polyol metabolism compromises NADPH-dependent GSH regeneration.

Hexosamine injury is a proposed mechanism; Non-glycemic risks also matter.

Slide 71 · Primary source and scope

Source for this lecture: Robbins, Cotran & Kumar, Pathologic Basis of Disease, 11th ed. (2026).

Principal section: “Chronic Complications of Diabetes.”

Morphologic context: “Morphology of Chronic Complications of Diabetes.”

Clinical context: “Clinical Manifestations of Chronic Diabetes.”

Conceptual schematics are original, editable teaching diagrams; no histopathology image is represented.